Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy. (2018)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/tan.13275
PubMed Identifier: 29667374
Publication URI: http://europepmc.org/abstract/MED/29667374
Type: Journal Article/Review
Parent Publication: HLA
ISSN: 2059-2302